Clinical Trials Browser

Carcinoma, Ovarian Epithelial × spartalizumab × 1 year × Clear all

NCT03294694 2025-05-31

Ribociclib + PDR001 in Breast Cancer and Ovarian Cancer

Phase 1 Terminated

BreastGynecologic

Carcinoma, Ovarian Epithelial, Breast Neoplasms